Authors: Connolly, KC Peake, MD Halpin, DMG Golightly, L Turbitt, ML

Citation: Kc. Connolly et al., Challenging current asthma treatment guidelines - Improved control of asthma symptoms with nebulised budesonide in patients with severe asthma receiving continuous oral steroids, DIS MANAG H, 7(4), 2000, pp. 217-225

Authors: Campbell, LM Anderson, TJ Parashchak, MR Burke, CM Watson, SA Turbitt, ML

Citation: Lm. Campbell et al., A comparison of the efficacy of long-acting beta(2)-agonists: eformoterol via Turbohaler (R) and salmeterol via pressurized metered dose inhaler or Accuhaler (R), in mild to moderate asthmatics (vol 93, pg 370, 1999), RESP MED, 93(7), 1999, pp. NIL_10-244

Authors: Campbell, LM Anderson, TJ Parashchak, MR Burke, CM Watson, SA Turbitt, ML

Citation: Lm. Campbell et al., A comparison of the efficacy of long-acting beta(2)-agonists: eformoterol via Turbohaler (R) and salmeterol via pressurized metered dose inhaler or Accuhaler (R), in mild to moderate asthmatics, RESP MED, 93(4), 1999, pp. 236-244

Authors: Matthews, EE Curtis, PD McLain, BI Morris, LS Turbitt, ML

Citation: Ee. Matthews et al., Nebulized budesonide versus oral steroid in severe exacerbations of childhood asthma, ACT PAEDIAT, 88(8), 1999, pp. 841-843